What is the medical insurance reimbursement policy for avatrombopag?
Avatrombopag (Avatrombopag) is a medicine used to treat certain types of thrombocytopenia. It belongs to a class of drugs called thrombopoietin receptor agonists (TPO-Ragonists). This class of drugs helps prevent or treat conditions associated with low thrombocytopenia by stimulating platelet production in the bone marrow to increase platelet numbers.
Avatrombopag has been launched in China and has been included in medical insurance. Patients can purchase avatrombopag in China at a price of about three to four thousand yuan. Please consult the local hospital pharmacy for specific prices and medical insurance reimbursement. The cheaper generic drug abroad is avatrombopag, which is mainly marketed in Laos and Bangladesh. The price ranges from a few hundred yuan to about a thousand yuan, and the ingredients of the original drug and the generic drug are basically the same.
Avatrombopag is primarily used to treat adults with chronic immune thrombocytopenia (ITP). ITPIt is a disease caused by an immune system abnormality. The patient's immune system mistakenly attacks and destroys platelets, resulting in an insufficient number of platelets. This can lead to bleeding tendencies such as bleeding from the skin, bleeding gums, or in more severe cases, internal bleeding.
Using avatrombopag can help increase platelet counts, which can reduce or prevent bleeding and improve patients' quality of life. It is usually taken as an oral medication, and the doctor will prescribe the appropriate dosage and treatment plan based on the patient's specific condition.
Although avatrombopag has shown good results in treatingITP, there are still some potential side effects and precautions, including headache, fatigue, nausea, etc. Therefore, before using this drug, patients should have a detailed discussion with their doctor and use it as directed. Additionally, avatrombopag may interact with other medications, so patients should provide their doctor with information about all medications they are taking to ensure safe use.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)